Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - CASH FROM OPERATIONS
Cash from Operations FATE - Fate Therapeutics, Inc.
-132 M
LAST VALUE
9.88%
2 YEAR CAGR
-27.90%
5 YEAR CAGR
-24.01%
10 YEAR CAGR